191 related articles for article (PubMed ID: 11872915)
1. Emergent use of anticoagulation for treatment of patients with ischemic stroke.
Adams HP
Stroke; 2002 Mar; 33(3):856-61. PubMed ID: 11872915
[TBL] [Abstract][Full Text] [Related]
2. Balance of symptomatic pulmonary embolism and symptomatic intracerebral hemorrhage with low-dose anticoagulation in recent ischemic stroke: a systematic review and meta-analysis of randomized controlled trials.
Geeganage CM; Sprigg N; Bath MW; Bath PM
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1018-27. PubMed ID: 22516428
[TBL] [Abstract][Full Text] [Related]
3. Considering the role of heparin and low-molecular-weight heparins in acute ischemic stroke.
Moonis M; Fisher M
Stroke; 2002 Jul; 33(7):1927-33. PubMed ID: 12105378
[TBL] [Abstract][Full Text] [Related]
4. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
[TBL] [Abstract][Full Text] [Related]
5. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
Kamphuisen PW; Agnelli G
Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulants for acute ischaemic stroke.
Sandercock PA; Counsell C; Kamal AK
Cochrane Database Syst Rev; 2008 Oct; (4):CD000024. PubMed ID: 18843603
[TBL] [Abstract][Full Text] [Related]
7. Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association).
Coull BM; Williams LS; Goldstein LB; Meschia JF; Heitzman D; Chaturvedi S; Johnston KC; Starkman S; Morgenstern LB; Wilterdink JL; Levine SR; Saver JL; ;
Stroke; 2002 Jul; 33(7):1934-42. PubMed ID: 12105379
[No Abstract] [Full Text] [Related]
8. Intravenous Thrombolysis in Patients with Acute Ischemic Stroke after a Reversal of Dabigatran Anticoagulation with Idarucizumab: A Real-World Clinical Experience.
Šaňák D; Jakubíček S; Černík D; Herzig R; Kunáš Z; Mikulík R; Ostrý S; Reif M; Rohan V; Tomek A; Veverka T
J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2479-2483. PubMed ID: 29807757
[TBL] [Abstract][Full Text] [Related]
9. Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudy.
Homma S; Thompson JL; Qian M; Ye S; Di Tullio MR; Lip GY; Mann DL; Sacco RL; Levin B; Pullicino PM; Freudenberger RS; Teerlink JR; Graham S; Mohr JP; Labovitz AJ; Buchsbaum R; Estol CJ; Lok DJ; Ponikowski P; Anker SD;
Circ Heart Fail; 2015 May; 8(3):504-9. PubMed ID: 25850425
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulation for the acute management of ischemic stroke.
Robinson AA; Ikuta K; Soverow J
Yale J Biol Med; 2014 Jun; 87(2):199-206. PubMed ID: 24910565
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulation in ischemic stroke: opportunities in arterial disease.
van Gijn J; Algra A
Cerebrovasc Dis; 2005; 20 Suppl 2():101-8. PubMed ID: 16327259
[TBL] [Abstract][Full Text] [Related]
12. The safety and usefulness of low molecular weight heparins and unfractionated heparins in patients with acute stroke.
Kiphuth IC; Köhrmann M; Huttner HB; Schellinger PD
Expert Opin Drug Saf; 2009 Sep; 8(5):585-97. PubMed ID: 19614560
[TBL] [Abstract][Full Text] [Related]
13. Predicting Hemorrhagic Transformation of Acute Ischemic Stroke: Prospective Validation of the HeRS Score.
Marsh EB; Llinas RH; Schneider ALC; Hillis AE; Lawrence E; Dziedzic P; Gottesman RF
Medicine (Baltimore); 2016 Jan; 95(2):e2430. PubMed ID: 26765425
[TBL] [Abstract][Full Text] [Related]
14. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators.
JAMA; 1998 Apr 22-29; 279(16):1265-72. PubMed ID: 9565006
[TBL] [Abstract][Full Text] [Related]
15. Novel oral anticoagulant management issues for the stroke clinician.
Wassef A; Butcher K
Int J Stroke; 2016 Oct; 11(7):759-67. PubMed ID: 27465882
[TBL] [Abstract][Full Text] [Related]
16. Nonvitamin-K-antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and previous stroke or transient ischemic attack: An updated systematic review and meta-analysis of randomized controlled trials.
Ntaios G; Papavasileiou V; Diener HC; Makaritsis K; Michel P
Int J Stroke; 2017 Aug; 12(6):589-596. PubMed ID: 28730948
[TBL] [Abstract][Full Text] [Related]
17. Anticoagulation in patients with acute ischemic stroke and atrial fibrillation--a balance of risks and benefits.
Beri A; Punnam SR
Cardiovasc Drugs Ther; 2008 Oct; 22(5):419-25. PubMed ID: 18642133
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulation in cerebral ischemia.
Weksler BB; Lewin M
Stroke; 1983; 14(5):658-63. PubMed ID: 6658947
[TBL] [Abstract][Full Text] [Related]
19. Are anticoagulants better than antiplatelet agents for treatment of acute ischemic stroke?
Griffin G
Am Fam Physician; 2003 Oct; 68(7):1307-8. PubMed ID: 14567484
[No Abstract] [Full Text] [Related]
20. Full heparin anticoagulation should not be used in acute ischemic stroke.
Sandercock P
Stroke; 2003 Jan; 34(1):231-2. PubMed ID: 12511780
[No Abstract] [Full Text] [Related]
[Next] [New Search]
